US-Canada trade war tests deep manufacturing ties between Detroit and Windsor

VITAL CROSS-BORDER SUPPLY CHAINS

Detroit remains one of the centres of North America’s automotive industry, with the region producing more than 1.7 million vehicles a year.

Many of the parts and materials used in those vehicles come from Canada.

The Canada Border Services Agency describes Windsor-Detroit as the country’s most important trade corridor, carrying about 30 per cent of Canada-US trade by truck.

One Detroit aluminium supplier, which asked not to be named, said the trade dispute was making it more difficult to do business across the border.

The company has been supplying manufacturers for more than 75 years.

“We’ve always had a good relationship with a lot of Canadian aluminium mills. And it’s becoming more difficult from a price point to work with them,” a representative told CNA.

Its biggest concern is what happens if tariffs make it increasingly difficult to source the materials it needs.

“Best-case scenario, I would say, we go back to the good old days. We forget any of this ever happened,” the representative added.

“Worst-case scenario is everything dries up. Eventually, it might come to the point where we cannot source a lot of our material that we rely on.”

Source link

Telit Cinterion to Onshore its Trusted Manufacturing to the United States

The largest western IoT player to onshore manufacturing of cellular modules and products in the U.S. with production starting in October 2026

• Pennsylvania facility: New manufacturing facility in the heart of the nation’s largest defense industrial complex establishes domestic production capacity to support critical infrastructure customers, advances America’s technology manufacturing base, and creates local jobs.
• Location is key: Pennsylvania supports Telit Cinterion’s position as the leading IoT module vendor to critical national infrastructure, defense and mission critical applications globally.
• First in industry: Telit Cinterion is bringing its pioneering trusted and secure technology, developed over 30 years in the U.S. and allied nations, to be manufactured domestically.

BOCA RATON, Fla., Sept. 2, 2026 /PRNewswire/ — Telit Cinterion, a global Internet of Things (IoT) enabler, today announced that it is expanding its global manufacturing apparatus by adding operations in the United States. From the new facility in Bristol, Pennsylvania, starting in October 2026, Telit Cinterion will serve the American and global markets with cellular 4G and 5G IoT modules, and OEM customer products such as routers and gateways.

The 8,000 square-foot facility will house manufacturing, testing, and quality assurance. Support functions including engineering and supply chain will be supported by the company’s existing offices in Research Triangle Park, North Carolina, and Boca Raton, Florida. The first phase of the initiative is expected to create at least 50 high-value jobs.

The start of U.S. production marks the first phase of Telit Cinterion’s long-term commitment to expanding domestic capabilities. The new operation establishes a foundation for continued investment in U.S. manufacturing, workforce development, and supply chain resiliency.

“The Bristol facility represents an important step in strengthening trusted technology supply chains and increasing domestic manufacturing capacity for IoT connected devices and AI-enabled solutions,” said Paolo Dal Pino, Telit Cinterion CEO. “It on shores our trusted manufacturing capability designed to provide U.S. and global customers with, greater traceability, quality assurance, operational resilience, and greater supply chain transparency that aligns with new regulations in the U.S. and western countries.”
 

More information about Telit Cinterion U.S. manufacturing may be found here. 

About Telit Cinterion

Telit Cinterion is a global IoT leader with over 30 years of innovation experience. It provides modules, connectivity plans and services, platforms, and secure, scalable custom solutions.

Telit Cinterion’s product portfolio supports mission-critical applications across industries. In addition, it simplifies lifecycle management and device-to-cloud security. The company helps enterprises connect, manage and grow their IoT systems with confidence.

OEMs, system integrators and service providers worldwide trust Telit Cinterion. The company drives digital transformation and unlocks the power of connected technology.

For more information, follow us on YouTube, X, LinkedIn and Facebook. Visit telit.com or subscribe to receive our marketing communications.

Copyright © 2026 Telit IoT Solutions Holding Ltd. and/or its affiliated companies. All rights reserved. Telit Cinterion, Telit, OneEdge, Cinterion, and all associated logos are trademarks and/or registered trademarks of Telit Communications S.p.A, Telit Communications LTD, Telit IoT Solutions Holding Ltd. and/or their affiliated companies in the United States and/or other countries. Other names used herein may be trademarks of their respective owners.

Media Contacts

Greg Oppenheim
Telit Cinterion
+1 949-540-1278
Greg.Oppenheim@telit.com

Casey Bush
GRC for Telit Cinterion
telit@globalresultspr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/telit-cinterion-to-onshore-its-trusted-manufacturing-to-the-united-states-302868058.html

SOURCE Telit Cinterion

Source link

Telit Cinterion to Onshore its Trusted Manufacturing to the United States

The largest western IoT player to onshore manufacturing of cellular modules and products in the U.S. with production starting in October 2026

• Pennsylvania facility: New manufacturing facility in the heart of the nation’s largest defense industrial complex establishes domestic production capacity to support critical infrastructure customers, advances America’s technology manufacturing base, and creates local jobs.
• Location is key: Pennsylvania supports Telit Cinterion’s position as the leading IoT module vendor to critical national infrastructure, defense and mission critical applications globally.
• First in industry: Telit Cinterion is bringing its pioneering trusted and secure technology, developed over 30 years in the U.S. and allied nations, to be manufactured domestically.

BOCA RATON, Fla., Sept. 2, 2026 /PRNewswire/ — Telit Cinterion, a global Internet of Things (IoT) enabler, today announced that it is expanding its global manufacturing apparatus by adding operations in the United States. From the new facility in Bristol, Pennsylvania, starting in October 2026, Telit Cinterion will serve the American and global markets with cellular 4G and 5G IoT modules, and OEM customer products such as routers and gateways.

The 8,000 square-foot facility will house manufacturing, testing, and quality assurance. Support functions including engineering and supply chain will be supported by the company’s existing offices in Research Triangle Park, North Carolina, and Boca Raton, Florida. The first phase of the initiative is expected to create at least 50 high-value jobs.

The start of U.S. production marks the first phase of Telit Cinterion’s long-term commitment to expanding domestic capabilities. The new operation establishes a foundation for continued investment in U.S. manufacturing, workforce development, and supply chain resiliency.

“The Bristol facility represents an important step in strengthening trusted technology supply chains and increasing domestic manufacturing capacity for IoT connected devices and AI-enabled solutions,” said Paolo Dal Pino, Telit Cinterion CEO. “It on shores our trusted manufacturing capability designed to provide U.S. and global customers with, greater traceability, quality assurance, operational resilience, and greater supply chain transparency that aligns with new regulations in the U.S. and western countries.”
 

More information about Telit Cinterion U.S. manufacturing may be found here. 

About Telit Cinterion

Telit Cinterion is a global IoT leader with over 30 years of innovation experience. It provides modules, connectivity plans and services, platforms, and secure, scalable custom solutions.

Telit Cinterion’s product portfolio supports mission-critical applications across industries. In addition, it simplifies lifecycle management and device-to-cloud security. The company helps enterprises connect, manage and grow their IoT systems with confidence.

OEMs, system integrators and service providers worldwide trust Telit Cinterion. The company drives digital transformation and unlocks the power of connected technology.

For more information, follow us on YouTube, X, LinkedIn and Facebook. Visit telit.com or subscribe to receive our marketing communications.

Copyright © 2026 Telit IoT Solutions Holding Ltd. and/or its affiliated companies. All rights reserved. Telit Cinterion, Telit, OneEdge, Cinterion, and all associated logos are trademarks and/or registered trademarks of Telit Communications S.p.A, Telit Communications LTD, Telit IoT Solutions Holding Ltd. and/or their affiliated companies in the United States and/or other countries. Other names used herein may be trademarks of their respective owners.

Media Contacts

Greg Oppenheim
Telit Cinterion
+1 949-540-1278
[email protected]

Casey Bush
GRC for Telit Cinterion
[email protected]

SOURCE Telit Cinterion

Source link

Shionogi gains $36.9 million U.S. order for Fetroja

KEY POINTS

• Shionogi secures $36.9 million after U.S. government exercises cefiderocol procurement option
• BARDA Project BioShield contract includes options for U.S. manufacturing, pathogen-focused development and pediatric label expansion
• Initial funding totals $119 million, with potential contract value rising to $482 million

The BARDA Project BioShield contract also covers U.S. manufacturing, priority-pathogen development and potential pediatric label expansion for cefiderocol. Photo by Pavel Danilyuk on Pexels
Pavel Danilyuk

Shionogi & Co. said on August 28 that the U.S. government had exercised a procurement option for cefiderocol, a treatment for Gram-negative bacterial infections, under a contract through the Biomedical Advanced Research and Development Authority’s Project BioShield program.

The exercised option will bring $36.9 million to the Shionogi group. Cefiderocol is sold in the United States under the brand name Fetroja.

Shionogi signed the contract with the U.S. government on April 8 as part of Project BioShield, a U.S. Department of Health and Human Services program designed to accelerate the research, development, procurement and supply of medical countermeasures against chemical, biological, radiological and nuclear threats.

Under the agreement, Shionogi initially received $119 million in funding. The contract includes multiple related options, including the establishment of a U.S. pharmaceutical manufacturing site for cefiderocol, development targeting infections caused by high-priority pathogens considered biological threats, and a supplemental new drug application to the U.S. Food and Drug Administration to expand the drug’s label for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in pediatric patients.

If those options advance, total funding under the contract could reach as much as $482 million, the company said.

Shionogi said the impact of the procurement option on its consolidated earnings for the fiscal year ending March 2027 would be minimal.

Cefiderocol is marketed in the United States for adult patients with complicated urinary tract infections, including pyelonephritis, caused by certain Gram-negative bacteria, as well as hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. The drug is also sold in multiple markets including Japan, Europe and Taiwan.

Shionogi is also working with the Global Antibiotic Research and Development Partnership and the Clinton Health Access Initiative to prepare for broader patient access to cefiderocol in low- and middle-income countries and upper-middle-income countries, the company said. Antimicrobial resistance is a major public health concern globally, and the company said an estimated 1.14 million people died worldwide in 2021 from AMR.

Source link

ISM Manufacturing PMI August 2026: Expansion Slows Amid Tariff and War Concerns – News and Statistics

Sep 1, 2026

The U.S. manufacturing sector continued its expansion in August, marking the eighth straight month of growth, as the Institute for Supply Management‘s latest Purchasing Managers Index came in at 54.6%—a decline of one full percentage point from July’s figure. ISM also reported that the broader economy has now grown for 22 consecutive months. Any reading below the 50% threshold signals contraction within the industry.

Meanwhile, the S&P Global U.S. Manufacturing PMI held steady at 53.9%, matching its July level. Susan Spence, chair of ISM’s Manufacturing Business Survey Committee, said during a Monday media call that despite the ongoing expansion, the Iran war and tariff threats remain the foremost concerns for the manufacturing sector.

Survey comments in August were split, with 42% positive and 58% negative, translating to a 1-to-1.4 ratio of positive to negative sentiment, according to Spence’s news release. Among the negative remarks, pricing volatility was cited in 57%, extended lead times in 46%, the Iran war in 30%, and tariffs in 29%.

Five of the six largest manufacturing industries saw growth in August: transportation equipment, petroleum and coal products, machinery, computer and electronic products, and food, beverage and tobacco products.

The New Orders Index rose for the eighth consecutive month, registering 53.7%—a drop of 3 percentage points from July’s 56.7%. The Production Index came in at 58.3%, slightly lower by 0.2 percentage point compared to July’s 58.5%. The Prices Index stayed in expansion territory at 71.1%, unchanged from the prior month. The Backlog of Orders Index fell to 51.8%, down 3.2 percentage points from July’s 55%. The Employment Index slipped to 51.2%, a 1.6-percentage-point decrease from July’s 52.8%, with the sector adding 5,000 jobs in July.

The Supplier Deliveries Index pointed to slower performance for the ninth month in a row, following a single month in faster territory. It registered 59.3%, up 0.4 percentage point from July’s 58.9%. This is the only ISM PMI Report index where a reading above 50% denotes slower deliveries. The Inventories Index stood at 50.6%, down 0.6 percentage point from July’s 51.2%. The Customers Inventories Index climbed to 42.8%, a 2.1-percentage-point increase from the 40.7% recorded in July. The New Export Orders Index edged up 0.2 percentage point to 53.2%, compared to 53% the previous month. The Imports Index fell to 52.5%, a 3.2-percentage-point decline from July’s 55.7%.

Among ISM’s four demand indicators, three—New Orders, Backlog of Orders, and New Export Orders—remained in expansion, while the Customers Inventories Index stayed in too low territory, contracting at a faster pace. A too low reading on the Customers Inventories Index is typically viewed as a positive sign for future production.

Spence noted that August manufacturing activity stayed in expansion, though it lost ground in several key metrics, particularly New Orders, Backlog, and Imports. Of the five subindexes feeding into the PMI, only Supplier Deliveries accelerated compared to the prior month, signaling a continued slowdown in the supply chain.

Numerous respondents pointed to tariffs, inflation, and supply chain disruptions as drags on their operations. One respondent from the chemical products industry lamented that the economy was interfering with otherwise strong business, citing price escalations from tariffs and the Strait of Hormuz conflict as threats to sales and customer purchasing power. A respondent in the computer and electronic products sector described a fresh supply chain crisis, more severe and complex than the one seen during and after COVID-19, driven by AI infrastructure demands and global market volatility tied to the Middle East war and shifting trade regulations. The steel industry has also felt the impact, most recently from 50% tariffs imposed by Canada that mirrored new U.S. tariffs.

Spence expressed less optimism about this month’s results compared to last month’s. She highlighted that this was the first time she had observed a drop exceeding three points in three significant areas. While demand sentiment remains broadly positive, it has weakened, and she voiced uncertainty about customer behavior, indicating she is beginning to see warning signs.

Source link

Palm Trees to Seaweed: Boosting U.S. Manufacturing

Mingyu Qiao will use an anaerobic digestion process to transform seaweed into a sustainable replacement for palm oil

Palm oil and palm kernel oil are versatile oleochemical feedstocks widely used in food and personal care products and can be converted into industrial products such as biolubricants and bio-based plasticizers.

Despite its ubiquity, though, there are serious problems with palm oil. Palm oil production has led to deforestation and biodiversity loss, as well as unjust labor practices in Southeast Asia, where the majority of the world’s palm oil supply is produced.

Because it is derived from a tropical plant, the United States currently relies on imports to meet 100% of its demand for this critical platform chemical across the food, cosmetics, industrial lubricants, and plasticizer sectors creating significant supply chain vulnerabilities.

Mingyu Qiao, assistant professor of innovation and entrepreneurship in the Department of Nutritional Sciences (CAHNR), has received a $1.875 million grant from the Department of Energy’s Alternative Fuels and Feedstocks Office to turn seaweed into a replacement for palm oil and other medium-chain fatty acids (MCFAs) like coconut oil.

Seaweed farming has already established a foothold in Connecticut and New England as a sustainable and easy-to-grow crop.

Not only doesn’t seaweed consume fertilizers, water, or pesticides, as other crops do, but it also acts as a natural filter to clean the water in which it grows. Seaweed can be produced rapidly and on a large scale without competing for space with land-based crops.

“With seaweed, you can just put it in the ocean, and it’ll grow itself,” Qiao says. “You don’t need to apply any pesticides or fertilizers because the ocean has all the nutrients it needs.”

Qiao is using sugar kelp, a popular edible seaweed that is native to and already produced in Connecticut’s waters, for his research.

Mingyu Qiao poses for a photo in his office in the Advanced Technology Laboratory (ATL). (Jason Sheldon/UConn Photo)

Qiao is using a biological process known as arrested anaerobic digestion to transform seaweed into MCFAs. Anaerobic digestion is a natural process through which bacteria break down organic matter in the absence of oxygen.

Normally this process produces methane, a potent greenhouse gas. However, the natural salinity of seaweed inhibits methane-producing microorganisms, redirecting the process toward volatile fatty acid production. These acids can then be separated and upgraded into medium-chain fatty acids (MCFAs), creating a more sustainable pathway.

This project is a collaboration with the Idaho National Laboratory, the recipient of $200,000 of the grant. The Laboratory will develop a method for preserving seaweed biomass long enough for it to be processed. Normally, seaweed rots within a few days of being out of the water. By adding lactic acid bacteria – the same bacteria found in yogurt – the researchers can stabilize and store the seaweed for months.

“That is the biggest problem for seaweed compared with something like corn or soybeans,” Qiao says. “This will solve that problem.”

Because the MCFAs Qiao’s team will produce are derived from seaweed, they can be used in all industries, like food and personal care, that require additives to be all-natural.

“For anything that comes into contact with the body, consumers increasingly prefer natural or bio-based materials because petroleum-derived products may contain trace impurities, some of which could pose toxicological or carcinogenic risks,” Qiao says.

This work will help support the U.S.’s supply chain resilience of critical chemicals and materials.

“For critical materials, [it’s important to be able to] produce them domestically,” Qiao says. “Even if it’s a little bit more expensive, those companies are willing to pay for that because it’s more secure. You can fully control that.”

This project is a collaboration between researchers in the College of Agriculture, Health and Natural Resources and the College of Engineering with co-PIs Baikun Li, professor in the Department of Civil & Environmental Engineering; Jeffrey McCutcheon and Xiao-Dong Zhou, professors, and Burcu Beykal, assistant professor, in the Department of Chemical & Biomolecular Engineering; and Bradley Wahlen, research scientist at Idaho National Laboratory. All UConn faculty are part of the Center for Clean Energy Engineering (C2E2).

Source link

MFN Program Grows to 26 Drugmakers as Nine More Commit to $19.6B in US Manufacturing

President Donald J. Trump announced nine new Most-Favored-Nation (MFN) agreements with pharmaceutical manufacturers on August 31, bringing the program’s total roster to 26 companies. The administration says that group now accounts for 89% of the branded drug market,1 a milestone with direct implications for how supply chain and market access teams plan pricing, procurement, and Medicaid formulary strategy heading into 2027.

Nine more manufacturers sign on

The newly announced participants are a group of mid-sized manufacturers:

• Alcon
• Astellas Pharma
• BeOne Medicines
• BridgeBio
• CSL
• Kyowa Kirin
• Sun Pharma
• Teva Pharmaceuticals
• UCB

The products affected span a wide swath of costly and chronic therapeutic areas, including hemophilia, Parkinson’s disease, macular degeneration, glaucoma, liver disease, dermatologic conditions, and multiple cancers.1 Under the deals, every state Medicaid program gains access to MFN pricing on these companies’ products, which the White House projects will translate into billions of dollars in aggregate savings.1 A companion White House fact sheet frames the agreements as closing off the ability of other countries to use price controls to benefit from American drug innovation without paying comparable prices.1

Manufacturing and supply chain commitments take center stage

For supply chain and commercialization leaders, the more consequential piece may be what’s attached to the pricing deals rather than the pricing itself. The nine companies have collectively pledged at least $19.6 billion in near-term U.S. manufacturing investment, and several are directing material toward the Strategic Active Pharmaceutical Ingredients Reserve, a stockpile meant to reduce dependence on foreign API sources and buffer against future supply disruptions.1

Individual contributions include:

• UCB: 163 tons of levetiracetam, an anticonvulsant
• Sun Pharma: 71.4 tons of clindamycin and 6.75 tons of doxycycline, both antibiotics
• Teva Pharmaceuticals: 45 metric tons of metronidazole (antibiotic/antiprotozoal) and 4.8 tons of amlodipine (antihypertensive)
• Astellas: 25 kg of tacrolimus, an immunosuppressant used in transplant care

For sourcing and procurement teams, these donations are worth tracking as an early signal of how manufacturers may reallocate API supply commitments going forward.

What it means for market access

The Medicaid provisions are the piece most relevant to market access and payer-strategy teams, though industry watchers caution the practical effect on patients may be limited. Lindsay Bealor Greenleaf, head of market access policy strategy at ADVI, told our sister publication Pharmaceutical Executive that Medicaid patients typically already pay only $4 to $8 out of pocket, and that the financial impact of the voluntary deals falls on manufacturers rather than patients. That distinction matters for commercialization planners weighing how MFN participation will affect net pricing and rebate structures rather than front-line patient access.

The road to 26 agreements

The nine deals build on momentum going back to May 2025, when the MFN executive order was signed, followed two months later by letters sent to 17 major manufacturers directing them to bring U.S. list prices in line with the lowest price charged in other developed markets.2 According to the White House, all 17 of those companies have since signed on.1 Combined with today’s additions, the MFN roster now includes Pfizer, AstraZeneca, EMD Serono, Eli Lilly, Novo Nordisk, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, Sanofi, Johnson & Johnson, AbbVie, Regeneron, Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB.1

What remains undone

Even with 26 manufacturers now committed, the administration is pushing Congress to pass the Great Healthcare Plan, broader legislation aimed at lowering drug prices and insurance premiums, increasing accountability for insurers, and expanding price transparency.3 Unlike the manufacturer-by-manufacturer MFN deals, that agenda depends on legislative action, meaning its outcome, and any further supply chain or market access implications, rests with lawmakers rather than executive negotiation.

References

1. Fact Sheet: President Donald J. Trump Announces Deal with Nine Additional Pharmaceutical Manufacturers to Lower Drug Prices for Americans, The White House, August 31, 2026. View source

2. White House to announce new drug pricing deals with biotechs, Bloomberg News reports, Reuters, August 26, 2026. View source

3. Fact Sheet: President Donald J. Trump Calls on Congress to Enact The Great Healthcare Plan, The White House, January 15, 2026. View source

Source link

NeoVolta Announces Strategic U.S. Battery Cell Supply and BESS Manufacturing Collaboration with SK On

Five-Year Agreement Secures 9 GWh of U.S.-Manufactured LFP Cell Supply for NeoVolta Power

Additional 9 GWh Cell Supply and Pack Purchase Arrangement, Under Which SK On Will Purchase Energy Storage Packs from NeoVolta Power From 2027 through 2031, Expanding Total Collaboration to 18 GWh

SAN DIEGO, Aug. 31, 2026 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV) (“NeoVolta” or the “Company”), a U.S.-based energy technology company delivering scalable energy storage solutions, today announced that its majority-owned subsidiary, NeoVolta Power, LLC (“NeoVolta Power”), has entered into a five-year strategic supply and manufacturing collaboration with SK On (“SK On”).

The collaboration begins with a signed agreement for SK On to supply 9 gigawatt-hours (“GWh”) of U.S.-manufactured lithium iron phosphate (“LFP”) battery cells to NeoVolta Power from 2027 through 2031. The agreement also establishes a framework for broader collaboration in which SK On will supply an additional 9 GWh of LFP cells to NeoVolta Power from 2027 through 2031, and NeoVolta Power will produce energy storage packs for purchase by SK On. Together, the initial cell-supply agreement and broader pack-manufacturing collaboration are expected to support up to 18 GWh of combined activity between the companies.

Key highlights

Get the latest news


delivered to your inbox

Sign up for The Manila Times newsletters

By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

• Long-term U.S. cell supply: The signed five-year agreement provides for 9 GWh of U.S.-manufactured LFP cell supply from SK On from 2027 through 2031, supporting NeoVolta Power’s Pendergrass production expansion.
• Broader pack purchase collaboration: The parties have established a framework under which SK On will provide an additional 9 GWh of LFP cells, NeoVolta Power will produce energy storage packs to be purchased by SK On from 2027 through 2031.
• Strategic manufacturing opportunity: The collaboration establishes SK On as a strategic supply chain partner and customer for NeoVolta Power’s domestic BESS manufacturing platform as demand for reliable, scalable power infrastructure grows across utility, commercial, industrial, AI data-center markets.
• Capacity expansion potential: The scale and multi-year nature of the relationship support NeoVolta Power’s evaluation of additional production capacity at Pendergrass, including a second production line designed around pouch-format LFP cells.
• Domestic supply-chain position: The collaboration advances NeoVolta Power’s strategy to pair U.S.-manufactured LFP cells with domestic BESS manufacturing for commercial, industrial and utility-scale BESS applications.

Strategic Collaboration

“This collaboration represents an important milestone in NeoVolta’s expansion into large-scale energy storage and the continued buildout of our U.S. manufacturing platform,” said Ardes Johnson, Chief Executive Officer of NeoVolta. “The initial agreement secures long-term access to U.S.-manufactured LFP cells for our Pendergrass production expansion, while the broader collaboration positions NeoVolta Power to manufacture energy storage packs for SK On. Together, these initiatives reinforce our strategy to build a domestic energy storage platform designed to meet growing demand for reliable, high-performance BESS solutions.”

The signed agreement establishes SK On as the primary cell supplier for NeoVolta Power’s LFP pouch-cell-based BESS products. The broader collaboration will leverage NeoVolta Power’s domestic manufacturing capabilities, with SK On supplying additional LFP cells for incorporation into battery energy storage packs designed and manufactured by NeoVolta Power and purchased by SK On.

“This partnership strengthens SK On’s position in the U.S. BESS market and brings together SK On’s U.S.-made LFP battery technology with NeoVolta Power’s growing energy storage manufacturing capabilities,” said Daejin Choi, Head of ESS Business at SK On. “We view NeoVolta Power as a strategic partner as we expand our presence in the U.S. energy storage market. By combining our respective capabilities, we will pursue new commercial opportunities and deliver competitive BESS solutions that meet evolving market needs.”

Domestic Manufacturing Platform

NeoVolta Power’s Pendergrass, Georgia facility is designed to manufacture BESS products for commercial, industrial and utility-scale applications. By pairing U.S.-manufactured LFP cells with U.S.-based battery BESS manufacturing, the Company believes its platform is positioned to serve customers seeking reliable and domestic content BESS solutions.

The Company’s initial Pendergrass production line remains on track to advance through commissioning and production-ramp activities. The multi-year strategic collaboration with SK On is expected to accelerate NeoVolta Power’s expansion from its initial Pendergrass production line to a two-line manufacturing platform targeting up to 8 GWh of annual BESS production capacity in 2028.

About NeoVolta

NeoVolta is an innovator in energy storage solutions dedicated to advancing reliable, high-performance power infrastructure for residential, commercial, and utility applications. With a focus on scalable technology, domestic manufacturing, and strategic partnerships, NeoVolta is positioned to support the accelerating transition toward resilient energy systems.

For more information, visit www.neovolta.com.

About SK On

SK On is a global leading battery & trading company committed to technological innovation for a better, sustainable future.

SK On aims to accelerate the green energy transition by leveraging its global production base and R&D capabilities, as well as its manufacturing and quality management know-how.

Headquartered in Seoul, South Korea, SK On has a worldwide presence with battery plants currently operating or in construction across the United States, Europe, and Asia.

For more information, visit: http://eng.sk-on.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable federal securities laws. Forward-looking statements include, among other things, statements regarding anticipated battery-cell supply, future battery-pack purchases, the implementation of future order documents, production and delivery schedules, future manufacturing capacity, the potential establishment and timing of additional production lines, domestic-content and supply-chain characteristics, the availability or applicability of tax incentives and credits, customer demand, market opportunities, and the anticipated benefits and future opportunities associated with the relationship between NeoVolta Power and SK On.

Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks and uncertainties include, among others, risks related to the parties’ ability to finalize and implement future order documents and commercial terms; satisfy technical and product-specification requirements; execute production ramps; obtain financing; source materials; meet regulatory or tax-credit requirements; respond to changes in tariffs or raw-material prices; and other risks described in NeoVolta’s filings with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. NeoVolta undertakes no obligation to update these statements except as required by law.

Contacts

NEOV Investors

Bryan Baritot

Alliance Advisors IR

[email protected]  

NEOV Media

Email: [email protected]

Source link

US PV manufacturing: how much capacity will actually be online by 2030? 

US PV manufacturing: how much capacity will actually be online by 2030?  – PV Tech

Skip to content

Close

Previous

Next

Source link

Canadian Solar Q2 Earnings Call Highlights — TradingView News

Canadian Solar CSIQ reported second-quarter 2026 revenue of $1.2 billion, reaching the high end of its guidance range, as stronger module shipments in the United States and accelerated energy-storage deliveries supported manufacturing performance. The company recorded a net loss attributable to shareholders of $77 million, or $1.40 per share, amid elevated freight costs and ramp-up expenses at its Jeffersonville, Indiana, solar-cell facility.

CEO Colin Parkin said Canadian Solar recognized revenue on 3.1 gigawatts of solar modules during the quarter and shipped 3.7 gigawatt-hours of energy-storage products, exceeding its storage shipment guidance. The company recognized revenue on 3.3 gigawatt-hours of storage solutions.

Gross margin was 13.9%, in line with management’s outlook. Parkin said profitability was affected by higher freight expenses tied to geopolitical uncertainty, as well as near-term costs associated with bringing the Jeffersonville facility into production. The manufacturing segment recorded an operating loss of $49 million.

U.S. Manufacturing Expansion and Backlog

Canadian Solar said its Jeffersonville plant is the first commercially operational heterojunction, or HJT, solar-cell manufacturing facility in the United States. Phase 1 of the facility is being ramped to 2.1 gigawatts of capacity and is expected to enter full-scale production on Oct. 1.

The company plans to begin installing equipment for Phase 2 before year-end, with total nameplate cell capacity at Jeffersonville expected to reach 6.3 gigawatts in 2027. Combined with Canadian Solar’s 10-gigawatt module plant in Texas, Parkin said the expansion would establish CSI Solar as one of North America’s largest integrated photovoltaic manufacturers.

Canadian Solar has secured more than 13 gigawatts of contracted backlog for domestically manufactured HJT and TOPCon n-type bifacial modules, with deliveries scheduled through 2029. Management said the backlog has a value exceeding $4.5 billion and includes agreements with U.S. utilities, independent power producers, developers and engineering, procurement and construction providers.

Parkin said nearly half of quarterly module volume was shipped to North America. He also said freight costs should decline as the company expands production in the region, reducing its dependence on overseas shipping. While freight costs are incorporated into contracts, Parkin said domestic manufacturing should reduce logistics costs over time.

Storage Deliveries and Data-Center Demand

Canadian Solar’s e-STORAGE unit delivered energy-storage systems to utility-scale projects in North America, Europe, the Middle East and Africa, Asia-Pacific, and Latin America. The company said storage results exceeded guidance because deliveries accelerated for two projects in the U.S. and Canada.

At quarter-end, e-STORAGE’s contracted backlog stood at $3.5 billion, including long-term service agreements covering 34 gigawatt-hours of projects. Parkin said demand associated with data centers is moving from discussions toward contracted opportunities.

Earlier in the year, e-STORAGE secured a contract with a major U.S. utility for a 500-megawatt, 2.5-gigawatt-hour direct-current project intended to support data-center grid infrastructure and resilience. Management said battery storage can help data centers address power availability and grid stability by increasing utilization of existing transmission infrastructure and responding to changes in electricity demand.

The company said its storage offering includes internally produced battery cells, the SolBank platform, power-conversion equipment, energy-management controls, engineering and commissioning services, and long-term service agreements.

Recurrent Energy Results and Portfolio Actions

Recurrent Energy, Canadian Solar’s project development business, generated $117 million of second-quarter revenue. CEO Dylan Marx said revenue declined sequentially because several project sales shifted into the second half of the year, though electricity sales increased following the commercial operation of a large solar asset in Spain.

Recurrent Energy reported an operating loss of $19 million, reflecting muted project sales and a $24 million impairment charge associated with an upcoming Latin American project sale.

During the quarter, Recurrent Energy brought a 426-megawatt solar asset in Spain into commercial operation and connected the 150-megawatt Carwarp project in Australia, which is supported by a long-term power purchase agreement with Microsoft. The unit also closed a $695 million construction financing and tax-equity package for its 330-megawatt Cobalt solar project in California. MUFG and NORD/LB provided construction loans, while Wells Fargo provided tax equity.

As of June 30, Recurrent Energy had secured grid interconnections for about 6 gigawatts of solar and 13 gigawatt-hours of storage projects globally, excluding operating projects. Its total development pipeline included nearly 22 gigawatts of solar and 84 gigawatt-hours of storage.

Marx said Recurrent Energy is pruning lower-margin opportunities, including scaling back its Europe, Middle East and Africa pipeline after reviewing permitting, technical and commercial viability. The company expects to selectively monetize operating, construction-stage and development assets in the second half to recycle capital, improve financial flexibility and address leverage.

Balance Sheet, Policy and Outlook

Chief Financial Officer Xinbo Zhu said operating cash flow was negative $181 million in the second quarter, primarily due to working-capital changes. Total assets rose to $16.1 billion, while total debt increased to $7.1 billion, mainly because of non-recourse construction financing for U.S. solar and storage projects under Recurrent Energy.

Capital expenditures were $172 million in the quarter, largely directed toward U.S. manufacturing initiatives. Canadian Solar expects full-year 2026 capital expenditures of approximately $1.3 billion, including spending on Jeffersonville’s second phase, expanded module capacity in Mesquite, Texas, and an energy-storage facility in Southeast Asia. The company ended the quarter with $1.9 billion in cash.

Management also discussed the Trump administration’s Section 232 announcement related to imported polysilicon and derivative products. Parkin said the company views the policy direction as supportive of domestic manufacturing and expects it to strengthen U.S. solar pricing. Thomas Koerner, Corporate Senior Vice President, said the stated value of the company’s 13-gigawatt domestic-module backlog does not yet include potential Section 232-related adjustments.

For the third quarter, Canadian Solar expects to recognize revenue from 3.5 gigawatts to 3.8 gigawatts of module shipments and deliver 3.4 gigawatt-hours to 3.8 gigawatt-hours of energy storage. Revenue is projected at $1.3 billion to $1.5 billion, with gross margin expected between 13.5% and 15.5%.

The company reiterated full-year U.S. shipment guidance of 6.5 gigawatts to 7 gigawatts of modules and 4.5 gigawatt-hours to 5.5 gigawatt-hours of energy storage. Parkin said Canadian Solar expects U.S. solar and storage volumes to increase sequentially in each remaining quarter of 2026.

About Canadian Solar CSIQ

Canadian Solar Inc CSIQ is a global renewable energy company that specializes in the design, development and manufacturing of solar photovoltaic (PV) modules and system solutions. Founded in 2001 and headquartered in Guelph, Ontario, the company has grown to become one of the world’s largest solar module suppliers. Canadian Solar offers a comprehensive portfolio of products, including mono- and multi-crystalline solar cells and modules, as well as advanced energy storage and system integration solutions tailored for residential, commercial and utility-scale applications.

In addition to manufacturing solar components, Canadian Solar provides end-to-end services encompassing project development, engineering, procurement and construction (EPC), as well as operations and maintenance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Source link